FDA.reportPublic FDA data

peginterferon beta-1a 0.063 MG per 0.5 ML Prefilled Syringe

RxCUI
1546181
RxNorm name
peginterferon beta-1a 0.063 MG per 0.5 ML Prefilled Syringe
Display name
peginterferon beta-1a 0.063 MG per 0.5 ML Prefilled Syringe
Full name
peginterferon beta-1a 0.063 MG per 0.5 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125499Plegridypeginterferon beta-1a351(a)Rx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Plegridy PenPEGINTERFERON BETA-1ABiogen Inc.08f0ea03-4e6d-195d-aef4-886e32befa952025-11-12Warnings, Adverse reactionsExact identifier
rxcui: 1546181

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
08f0ea03-4e6d-195d-aef4-886e32befa95peginterferon beta-1a 63 MCG in 0.5 ML Prefilled Syringe [PSN] · 0.5 ML peginterferon beta-1a 0.126 MG/ML Prefilled Syringe [SCD] · peginterferon beta-1a 0.063 MG per 0.5 ML Prefilled Syringe [SY] · peginterferon beta-1a 63 MCG per 0.5 ML Prefilled Syringe [SY]429These highlights do not include all the information needed to use PLEGRIDY ® safely and effectively. See full prescribing information for PLEGRIDY. PLEGRIDY (peginterferon beta-1a) injection, for subcutaneous or intramuscular use Initial U.S. Approval: 201420251021